Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of clindamycin + benzoyl peroxide topical gels on epidermal functions in healthy skin
2008-004860-37Phase 3Completed
- Sponsor
- Arcutis Biotherapeutics
- Start
- Sep 2008
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of clindamycin phosphate + benzoyl peroxide in healthy skin (3 arms), sponsored by Arcutis Biotherapeutics. Primary endpoint: Primary epidermal function variables. Started Sep 2008; status: completed.
02
Drugs
clindamycin phosphate + benzoyl peroxide
03
Conditions
healthy skin
Beyond the preview
Go deeper on 2008-004860-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004860-37.